Fused polypeptides comprising interleukin-4 polypeptide fragments
US5807996A · kind A · utility
0Cited by
6References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 1995 |
| Grant date | Sep 15, 1998 |
| Priority date | — |
| Expiry date | Jun 6, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16243
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mammalian proteins and muteins thereof, designated interleukin-4s (IL-4s), are provided which exhibit both B cell growth factor activity and T cell growth factor activity. Compounds of the invention include native human and murine IL-4s, muteins thereof, and nucleic acids which are effectively homologous to disclosed cDNAs, and/or which are capable of coding for mammalian IL-4s and their muteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.